Volex plc, the global supplier of complex assemblies for performance-critical applications and power products, was notified yesterday that on Friday 22 November, Daren Morris, Chief Financial Officer, exercised 35,809 of the 2016 share awards that vested in March this year under the rules of the 2009 Volex plc Performance Share Plan, through the Volex Group plc Employees' Share Trust (the "Trust").
On the same date, the Trust immediately sold 35,809 Ordinary Shares of 25 pence on Mr Morris's behalf at an average price of 121.54 pence per share.
Following this exercise, Mr Morris's shareholding in the Company is unchanged at 0.45% of the Company's issued share capital.
This announcement is made in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.
For further information please contact:
Volex plc +44 7909 995 887
Nat Rothschild, Executive Chairman
Daren Morris, Chief Financial Officer and Company Secretary
NOTIFICATION OF TRANSACTIONS BY DIRECTORS / PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED
Details of the Director / person discharging managerial responsibilities / person closely associated
Reason for the notification
Chief Financial Officer and Company Secretary
Initial notification / Amendment
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument
Ordinary 25 pence Shares
Nature of the transaction
Exercise of options and sale of shares
Price(s) and volume(s)
Exercise of 35,809 options to acquire shares at £0.25 per share and sale of all those shares at an average £1.215444 per share
- Aggregated volume
See 4 c) above
Date of the transaction
22 November 2019
Place of the transaction
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
Create your account: sign up and get ahead on news and events
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...